Studies on the anti-diabetic effect of sodium oxaloacetate.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D001786:Blood Glucose / Q000032:analysis / Q000494:pharmacology*; D003920:Diabetes Mellitus / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism; D004285:Dogs; D005260:Female; D005947:Glucose / Q000378:metabolism; D006029:Glycosuria; D006801:Humans; D007003:Hypoglycemia / Q000378:metabolism; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007275:Injections, Intravenous; D007515:Islets of Langerhans / Q000473:pathology; D008297:Male; D008875:Middle Aged; D010071:Oxaloacetates / Q000302:isolation & purification / Q000494:pharmacology*; D010944:Plants; D011817:Rabbits; D051381:Rats; D012964:Sodium
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D010071:Oxaloacetates; D012964:Sodium; D005947:Glucose